Rankings
▼
Calendar
VCEL (Vericel Corporation) Stock Financials & Earnings | Market Cap Arena
VCEL
Vericel Corporation
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$276M
Net Income (TTM)
$17M
EPS (TTM)
$0.31
Free Cash Flow (TTM)
$35M
Gross Margin
74.4%
Op. Margin
4.0%
Net Margin
6.0%
FCF Margin
12.7%
P/S Ratio (TTM)
6.1x
P/E Ratio (TTM)
101.6x
YoY Rev Growth
+16.5%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$41M
$27M
-$8M
Q2 23
$46M
$30M
-$6M
Q3 23
$46M
$31M
-$5M
Q4 23
$65M
$49M
$13M
Q1 24
$51M
$35M
-$5M
Q2 24
$53M
$37M
-$6M
Q3 24
$58M
$42M
-$2M
Q4 24
$75M
$58M
$18M
Q1 25
$53M
$36M
-$13M
Q2 25
$63M
$47M
-$2M
Q3 25
$68M
$50M
$3M
Q4 25
$93M
$73M
$22M
marketcaparena.com
Revenue Breakdown
VCEL
Vericel Corporation
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
9.9x
—
Q2 23
9.4x
—
Q3 23
9.1x
—
Q4 23
8.5x
—
Q1 24
8.1x
3721.0x
Q2 24
7.8x
2127.0x
Q3 24
7.4x
473.0x
Q4 24
7.1x
162.0x
Q1 25
7.0x
563.5x
Q2 25
6.7x
236.1x
Q3 25
6.5x
128.3x
Q4 25
6.1x
101.6x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$8M
-$1M
Q2 23
$10M
$6M
Q3 23
$7M
$600K
Q4 23
$10M
$2M
Q1 24
$7M
-$7M
Q2 24
$19M
$2M
Q3 24
$10M
$41M
Q4 24
$22M
$8M
Q1 25
$7M
-$8M
Q2 25
$8M
$22M
Q3 25
$22M
$19M
Q4 25
$15M
$802K
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$9M
Q2 23
$4M
Q3 23
$7M
Q4 23
$8M
Q1 24
$14M
Q2 24
$17M
Q3 24
$31M
Q4 24
$14M
Q1 25
$14M
Q2 25
$14M
Q3 25
$3M
Q4 25
$14M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+13.7%
+13.5%
Q2 23
+24.0%
+12.5%
Q3 23
+18.2%
+11.7%
Q4 23
+23.3%
+12.1%
Q1 24
+25.0%
+15.3%
Q2 24
+14.7%
+13.1%
Q3 24
+27.0%
+19.2%
Q4 24
+16.0%
+8.9%
Q1 25
+2.6%
+15.2%
Q2 25
+20.1%
+11.2%
Q3 25
+16.6%
+6.1%
Q4 25
+23.3%
+23.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$9M
21.3%
Q2 23
$9M
19.1%
Q3 23
$8M
17.4%
Q4 23
$7M
10.6%
Q1 24
$10M
19.2%
Q2 24
$10M
18.1%
Q3 24
$9M
15.9%
Q4 24
$8M
10.5%
Q1 25
$12M
21.9%
Q2 25
$10M
16.0%
Q3 25
$9M
12.9%
Q4 25
$8M
9.1%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$5M
$29M
Q2 23
$5M
$31M
Q3 23
$6M
$30M
Q4 23
$5M
$31M
Q1 24
$6M
$34M
Q2 24
$7M
$35M
Q3 24
$6M
$38M
Q4 24
$5M
$35M
Q1 25
$7M
$42M
Q2 25
$7M
$42M
Q3 25
$6M
$40M
Q4 25
$7M
$43M
marketcaparena.com
Revenue Segments
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$62M
$57M
$119M
Q2 23
$43M
$55M
$98M
Q3 23
$60M
$45M
$105M
Q4 23
$69M
$40M
$110M
Q1 24
$71M
$48M
$118M
Q2 24
$50M
$52M
$103M
Q3 24
$54M
$48M
$102M
Q4 24
$75M
$42M
$116M
Q1 25
$73M
$39M
$113M
Q2 25
$81M
$36M
$117M
Q3 25
$100M
$35M
$135M
Q4 25
$100M
$37M
$137M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
47M
-3.7%
Q2 23
48M
+0.4%
Q3 23
48M
+0.2%
Q4 23
51M
+6.0%
Q1 24
48M
-4.7%
Q2 24
49M
+1.1%
Q3 24
49M
+0.8%
Q4 24
52M
+6.4%
Q1 25
50M
-4.4%
Q2 25
50M
+0.9%
Q3 25
52M
+3.1%
Q4 25
52M
+0.3%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$152K
190
FY 15
$269K
190
FY 16
$269K
202
FY 17
$312K
205
FY 18
$421K
216
FY 19
$489K
241
FY 20
$455K
273
FY 21
$556K
281
FY 22
$539K
305
FY 23
$629K
314
FY 24
$664K
357
FY 25
$35K
8K
marketcaparena.com